COVID-19 effects on Women's Health


The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections. Journal of Clinical & Experimental Pathology covers all areas of clinical and experimental pathology. Articles such as research papers, review articles, commentaries and short communications leading to the development of Journal of clinical and experimental pathology.

As a result of the Coronavirus disease (COVID-19) pandemic, the world is facing one of the greatest challenges we have experienced in over a century. The economic consequences for society at large are potentially catastrophic. The health and social care sectors have reacted by providing emergency care on an unprecedented scale, while the scientific community has focused on developing new treatments and a vaccine to prevent future waves of the pandemic.

Evidence is emerging to suggest that certain conditions, such as obesity and hypertension, predispose some individuals to a worse outcome if they become infected, and that women may be less likely to die from COVID-19 than men. It is also currently believed that pregnant women are at no greater risk than the general population. There is an urgent need to determine whether these early observations are correct. Furthermore, we need to be sure that pregnancy outcomes are not affected by COVID-19 and that SARS-CoV-2 is not transmitted to the fetus during pregnancy or labour, nor to the infant through breast milk. There are so many questions that need to be answered to optimise care, avoid harm, reduce anxiety amongst women and their families, and inform health professionals and policymakers.

On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.


Robert Solomon

Editorial office

Journal of Clinical and Experimental Pathology


Reach Us: +1-947-333-4405